Featured Research

from universities, journals, and other organizations

New DNA-Based Vaccine Used To Fight Cancer

Date:
November 20, 1998
Source:
University Of Illinois At Chicago
Summary:
A promising new DNA-based vaccine that fights several forms of cancer has been developed by Edward Cohen, professor of microbiology and immunology at the University of Illinois at Chicago

A promising new DNA-based vaccine that fights several forms of cancer has been developed by Edward Cohen, professor of microbiology and immunology at the University of Illinois at Chicago.

"While this new treatment is not likely to cure the disease, we are hopeful it will extend the lives of cancer patients," says Cohen.

The vaccine will be used to treat breast, head/neck and cervical cancer and melanoma.

Cohen and his colleagues Tapas Das Gupta, professor and head of the department of surgical oncology, Barry Wenig, director of the division of head and neck surgery, and Joseph Connor, professor of obstetrics and gynecology, hope to begin Phase I human trials next year. They are actively looking for corporate sponsorship to support the trials. A patent for the technology was recently issued to the university.

The new vaccine involves the genetic modification of special types of cells to produce interleukin 2, a natural substance of the body that increases immunity to a wide variety of bacteria and viruses. The process is tailored to each patient by introducing DNA from the patient's tumor into the cells, where it can produce antigens that characterize the patient's cancer. The number of genetically modified cells is expanded and then administered to the patient as a vaccine. There are three main advantages to this treatment. First, only a small amount of tumor is needed to obtain the DNA. Second, the DNA from the tumor specifies an array of tumor antigens-this is important because tumor cells differ in their antigenic properties and by expressing as many antigens as possible, one can increase the chance of effectively treating the tumor. Third, because the DNA is placed in the cells, it becomes incorporated and is replicated as the cells divide.

"In every patient, tumor antigens are unique to that person's cancer," says Cohen. "This vaccine allows us to create specialized therapy for each patient using cells from their own body."

The therapy stimulates an immune response to the patient's tumor. Unlike chemotherapy and radiation, the treatment has been found to be non-toxic in pre-clinical studies.

One day, "this type of tumor vaccine will become an important part of the care of the cancer patient," says Cohen.


Story Source:

The above story is based on materials provided by University Of Illinois At Chicago. Note: Materials may be edited for content and length.


Cite This Page:

University Of Illinois At Chicago. "New DNA-Based Vaccine Used To Fight Cancer." ScienceDaily. ScienceDaily, 20 November 1998. <www.sciencedaily.com/releases/1998/11/981119175231.htm>.
University Of Illinois At Chicago. (1998, November 20). New DNA-Based Vaccine Used To Fight Cancer. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/1998/11/981119175231.htm
University Of Illinois At Chicago. "New DNA-Based Vaccine Used To Fight Cancer." ScienceDaily. www.sciencedaily.com/releases/1998/11/981119175231.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins